Evidence map›Paper›PMID 33688585›Full record

ReviewHeliyon2021

Impact of SARS-CoV-2 on the clinical outcomes and placental pathology of pregnant women and their infants: A systematic review.

Irina Oltean, Jason Tran, Sarah Lawrence, Brittany Ann Ruschkowski, Na Zeng, Cameron Bardwell, Youssef Nasr, Joseph de Nanassy, Dina El Demellawy

Open access · goldAbstract readReview
In one paragraph

Review in Heliyon, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. SARS- CoV-2 infection and oxidative stress in early-onset preeclampsia.Biochimica et biophysica acta. Molecular basis of disease · 2022
    Review
  11. Article
  12. Impact of maternal nutrition in viral infections during pregnancy.Biochimica et biophysica acta. Molecular basis of disease · 2021
    Review
  13. Article
  14. Review
  15. Article
  16. COVID-19 Deliveries: Maternal Features and Neonatal Outcomes.Journal of patient-centered research and reviews · 2021
    Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Irina OlteanChildren's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, K1H 8L1, Canada.
Jason TranDepartment of Medicine, University of Ottawa, Ottawa, Ontario, K1H 8M5 Canada.
Sarah LawrenceChildren's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, K1H 8L1, Canada.
Brittany Ann RuschkowskiDepartment of Medicine, University of Ottawa, Ottawa, Ontario, K1H 8M5 Canada.
Na ZengDepartment of Medicine, University of Ottawa, Ottawa, Ontario, K1H 8M5 Canada.
Cameron BardwellDepartment of Medicine, University of Ottawa, Ottawa, Ontario, K1H 8M5 Canada.
Youssef NasrDepartment of Medicine, University of Ottawa, Ottawa, Ontario, K1H 8M5 Canada.
Joseph de NanassyChildren's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, K1H 8L1, Canada.
Dina El DemellawyChildren's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, K1H 8L1, Canada.
University of Ottawa · CAChildren's Hospital of Eastern Ontario · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pregnant women are susceptible to viral infections due to physiological changes such as cell-mediated immunity. No severe adverse pregnancy or neonatal outcomes have been consistently reported in 2019 novel coronavirus disease (COVID-19) positive pregnancy cases. There are controversies around the role of COVID-19 in pregnancy. A systematic review was conducted to examine clinical maternal and neonatal clinical outcomes. Studies were included if they reported SARS-CoV-2 infection among pregnant women and/or COVID-19 positive neonates as validated by positive antibody testing or viral testing using polymerase chain reaction. Case series, case reports, case-control studies, and comparative studies were included. Eight hundred and thirty-seven records were identified, resulting in 525 records for level I screening. Forty-one were included after full-text review. Results suggest elevated rates of intensive care unit (ICU) admission, gestational diabetes, preeclampsia, C-sections, pre-term birth, and C-reactive protein (CRP) in comparison to pregnant women without SARS-CoV-2. Careful monitoring of pregnancies with SARS-CoV-2 is recommended.

Indexed as

COVID-19NeonatesPlacenta diseasesPlacental pathologyPregnant womenSARS-CoV-2

Identifiers

PMID33688585
PMCPMC7923950
OpenAlexW3134396240

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.